Tumorigenesis in neurofibromatosis: new insights and potential therapies.
about
Regulation of mixed lineage kinase 3 is required for Neurofibromatosis-2-mediated growth suppression in human cancerMerlin, a "magic" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survivalMultiple primary cranio-spinal tumours in a 13-year-old female with neurofibromatosis type 2 management strategy.Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation.p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.S100B and neurofibromin immunostaining and X-inactivation patterns of laser-microdissected cells indicate a multicellular origin of some NF1-associated neurofibromas.Succinate Dehydrogenase Subunit B (SDHB) Is Expressed in Neurofibromatosis 1-Associated Gastrointestinal Stromal Tumors (Gists): Implications for the SDHB Expression Based Classification of GistsInhibition of Cdc42-mediated activation of mixed lineage kinase 3 by the tumor suppressor protein merlin.Pheochromocytoma: the expanding genetic differential diagnosis.Point mutation in the NF2 gene of HEI-193 human schwannoma cells results in the expression of a merlin isoform with attenuated growth suppressive activity.Next-generation-sequencing-based risk stratification and identification of new genes involved in structural and sequence variations in near haploid lymphoblastic leukemia.Genetic modeling of Ras-induced human rhabdomyosarcoma.Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21(CIP1) levels in androgen-independent human prostate cancer cells.Proposing the use of dental pulp stem cells as a suitable biological model of neurofibromatosis type 1.
P2860
Q24301750-B51B5F5C-B6DA-4CFC-B630-D0F48B352D32Q28283076-EB9CC9D5-B7DA-471F-A4FE-F514FF6B9844Q30477143-D78F7B99-C60A-4057-8D63-C56BF416B4E6Q30495325-F64F9976-A335-4275-8465-D70730C2358EQ33745071-43076E19-F119-4EC4-A3CA-84C84621C073Q33933299-74941764-1B07-4D3C-B15D-3EF3425FAD18Q34771877-FDF4DB05-C13B-4E9C-ADC7-E24DEB23DBD8Q35049697-E3390CDD-3B12-41A1-BE4A-872846FF6C83Q35203185-6109042A-1067-445B-B7FA-4F253417DA04Q36445494-3B56399A-C148-4149-A934-A59DC9E6DA49Q39178745-4F65F389-AA48-4D1D-8D3D-AD7C22793437Q42154621-4D528238-6BD7-467C-8081-77BC146CEA01Q47784970-C4EB27BE-76B5-4688-B47D-A497239EA394Q53669260-5CBDC5D1-F4C6-456D-A8CB-8D6C53B15343
P2860
Tumorigenesis in neurofibromatosis: new insights and potential therapies.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Tumorigenesis in neurofibromatosis: new insights and potential therapies.
@ast
Tumorigenesis in neurofibromatosis: new insights and potential therapies.
@en
Tumorigenesis in neurofibromatosis: new insights and potential therapies.
@nl
type
label
Tumorigenesis in neurofibromatosis: new insights and potential therapies.
@ast
Tumorigenesis in neurofibromatosis: new insights and potential therapies.
@en
Tumorigenesis in neurofibromatosis: new insights and potential therapies.
@nl
prefLabel
Tumorigenesis in neurofibromatosis: new insights and potential therapies.
@ast
Tumorigenesis in neurofibromatosis: new insights and potential therapies.
@en
Tumorigenesis in neurofibromatosis: new insights and potential therapies.
@nl
P1476
Tumorigenesis in neurofibromatosis: new insights and potential therapies.
@en
P2093
P304
P356
10.1016/S1471-4914(01)01955-4
P577
2001-04-01T00:00:00Z